Covered recipient · General Payments record
DAVID MCALPINE
General Payments · PY2018–2023
$1,506.14
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $214.14 | 8 |
| Education | $84.99 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | $145.93 | 4 |
| Astellas Pharma US Inc | $139.28 | 4 |
| Sumitomo Pharma America, Inc. | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $20.54 | 07/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034286265 | CMS |
| Astellas Pharma US Inc | $22.29 | 10/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034560769 | CMS |
| Astellas Pharma US Inc | $84.99 | 10/10/2023 | Education | Undisputed | 01/23/2026 | 1034585693 | CMS |
| Astellas Pharma US Inc | $11.46 | 11/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034663939 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $16.91 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060911869 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $10.06 | 05/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060911867 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $16.36 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060911871 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $102.60 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060911873 | CMS |
| Sumitomo Pharma America, Inc. | $13.92 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1030847119 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.